News stories about Wright Medical Group (NASDAQ:WMGI) have been trending positive this week, Accern Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Wright Medical Group earned a media sentiment score of 0.46 on Accern’s scale. Accern also assigned news headlines about the medical device company an impact score of 47.0294586289672 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Here are some of the media stories that may have impacted Accern’s rankings:
Shares of WMGI opened at $19.40 on Tuesday. The firm has a market cap of $2,042.94, a PE ratio of -88.18 and a beta of 0.66. The company has a current ratio of 1.37, a quick ratio of 0.96 and a debt-to-equity ratio of 1.42. Wright Medical Group has a one year low of $19.04 and a one year high of $30.91.
Wright Medical Group (NASDAQ:WMGI) last issued its quarterly earnings results on Tuesday, February 27th. The medical device company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.06. The company had revenue of $217.60 million for the quarter, compared to analyst estimates of $215.69 million. Wright Medical Group had a negative return on equity of 3.78% and a negative net margin of 27.19%. sell-side analysts anticipate that Wright Medical Group will post -0.18 EPS for the current year.
Several brokerages have weighed in on WMGI. BidaskClub lowered Wright Medical Group from a “sell” rating to a “strong sell” rating in a research report on Friday, April 13th. ValuEngine lowered Wright Medical Group from a “sell” rating to a “strong sell” rating in a research report on Wednesday, April 11th. BMO Capital Markets dropped their target price on Wright Medical Group from $28.00 to $25.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 28th. Oppenheimer set a $25.00 target price on Wright Medical Group and gave the stock a “hold” rating in a research report on Wednesday, February 28th. Finally, Cantor Fitzgerald set a $30.00 target price on Wright Medical Group and gave the stock a “buy” rating in a research report on Monday, January 8th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $29.38.
COPYRIGHT VIOLATION WARNING: “Wright Medical Group (WMGI) Receiving Positive Media Coverage, Analysis Finds” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/04/24/wright-medical-group-wmgi-receiving-positive-media-coverage-analysis-finds.html.
About Wright Medical Group
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.